Sources | Names Used |
---|---|
CTRPv2 | tanespimycin:bortezomib (250:1 mol/mol) |
PharmacoGx | tanespimycin:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MRPL1 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
mRNA | TM9SF4 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
mRNA | NBR1 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-06 |
mRNA | NEDD9 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
mRNA | DNAJB2 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-06 |
mRNA | ADAT2 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-06 |
mRNA | PPA2 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
mRNA | TYW3 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
mRNA | YIPF2 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
mRNA | MEMO1 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |